Safety and Immunogenicity of an Investigational 4-Component Staphylococcus Aureus Vaccine with or Without AS03B Adjuvant: Results of a Randomized Phase I Trial.
HUMAN VACCINES & IMMUNOTHERAPEUTICS（2015）
Key words
adjuvant,immunogenicity,safety,Staphylococcus aureus,vaccine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined